您的购物车当前为空
Desmethyl cariprazine-d8是Desmethyl cariprazine的氘代标记物。Desmethyl cariprazine为Cariprazine的主要活性代谢产物之一,对人dopamine受体和5-hydroxytryptamine受体具有活性,其中人D2受体pEC50=8.90、D3受体pEC50=8.09、5-HT1A受体pEC50=6.28。Desmethyl cariprazine可抑制Quinpirole诱导的D2、D3和5-HT1A受体cAMP生成,并抑制5-hydroxytryptamine诱导的5-HT2B受体Ca2+释放,可用于schizophrenia、bipolar I disorder及bipolar disorder相关研究。
Desmethyl cariprazine-d8是Desmethyl cariprazine的氘代标记物。Desmethyl cariprazine为Cariprazine的主要活性代谢产物之一,对人dopamine受体和5-hydroxytryptamine受体具有活性,其中人D2受体pEC50=8.90、D3受体pEC50=8.09、5-HT1A受体pEC50=6.28。Desmethyl cariprazine可抑制Quinpirole诱导的D2、D3和5-HT1A受体cAMP生成,并抑制5-hydroxytryptamine诱导的5-HT2B受体Ca2+释放,可用于schizophrenia、bipolar I disorder及bipolar disorder相关研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Desmethyl cariprazine-d8 is the deuterium-labeled form of Desmethyl cariprazine. Desmethyl cariprazine is a primary active metabolite of cariprazine, exhibiting activity at human dopamine receptors and serotonin receptors, with human D2 receptor pEC50 = 8.90, D3 receptor pEC50 = 8.09, and 5-HT1A receptor pEC50 = 6.28. It inhibits forskolin-induced cAMP production at D2, D3, and 5-HT1A receptors and serotonin-induced Ca2+ release at 5-HT2B receptors. Desmethyl cariprazine is applicable in studies related to schizophrenia, bipolar I disorder, and bipolar disorders. |
| 分子量 | 421.43 |
| 分子式 | C20H30Cl2N4O |
| CAS No. | 1308278-85-4 |
| Smiles | ClC1=C(C=CC=C1Cl)N2C(C(N(CC[C@@H]3CC[C@@H](NC(NC)=O)CC3)C(C2([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H] |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多